Experimental cancer drug trial halted after early testing

NCT ID NCT06523803

Summary

This early-stage study tested whether a new drug called ZW171 was safe for people with advanced ovarian cancer, lung cancer, and other cancers that had spread. The trial enrolled 32 participants whose cancers had stopped responding to standard treatments. Researchers measured side effects and early signs of whether the drug might help shrink tumors, but the study was terminated before completion.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MESOTHELIN-EXPRESSING ADVANCED CANCERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Guys and St Thomas' NHS Foundation Trust

    London, SE1 9RT, United Kingdom

  • Icahn School of Medicine at Mount Sinai (ISMMS) - The Blavatnik Family-Chelsea Medical Center

    New York, New York, 10011, United States

  • Norton Cancer Institute

    Louisville, Kentucky, 40202, United States

  • Royal Marsden Hospital

    Sutton, SW3 6JJ, United Kingdom

  • Samsung Medical Center

    Seoul, 06351, South Korea

  • Sarah Cannon Research Institute

    Nashville, Tennessee, 37203, United States

  • Seoul National University Hospital

    Seoul, 03080, South Korea

  • The Catholic University of Korea, Seoul St. Marys Hospital

    Seoul, South Korea

  • The Christie NHS Foundation Trust

    Manchester, M20 4BX, United Kingdom

  • UPMC Hillman Cancer Center

    Pittsburgh, Pennsylvania, 15232, United States

  • Universitaetsklinikum Dresden

    Dresden, 01307, Germany

  • University of Colorado Health Sciences Center

    Aurora, Colorado, 80045, United States

  • University of Southern California - Norris Comprehensive Cancer Center

    Los Angeles, California, 90089, United States

  • University of Washington

    Seattle, Washington, 98195, United States

  • Yonsei University Health System - Severance Hospital

    Seoul, 03722, South Korea

Conditions

Explore the condition pages connected to this study.